DiscoBio News

Griffith researchers  Dr. Alex Cristino, Professor Emeritus Alan Mackay-Sim, and  Professor Vicky Avery – Head of Discovery Biology have been awarded $1,425,156.50 from the Medical Research Future Fund (MRFF) to develop new drugs to treat schizophrenia using patient derived stem cells. Professor Vicky Avery’s team will develop new image based assays to screen FDA-approved drugs against patient stem cell lines, with the objective to find those that restore cellular functions back to normal. For more information click here.

The first round of Pipeline Accelerator 2022-23 is now open: applications close 28th October 2022, 5pm (AEST). TIA has developed two voucher schemes to help Australian researchers and Small to Medium Enterprises (SMEs) subsidised access to one or more TIA facilities. This aims to support therapeutic development projects by providing up to $50,000 with 50% matching funding (co-investment) by the applicant.  For guidelines and more information visit https://www.therapeuticinnovation.com.au/voucher-schemes. Discovery Biology, Griffith University, provides high throughput screening capabilities including assay design and optimisation, with considerable expertise in high …

Tour de Cure raises vital funds to support the researchers, surgeons and clinicians who dedicate their lives to finding a cure for cancer. Soirée For A Cure – Saturday 25th June 2022 Hilton Brisbane Grand Ballroom   Photo: Professors Vicky Avery, Bernd Rehm, Chamindie Punyadeera and Kathy Andrews from Griffith University  

The Bridge program was launched in 2017 to help researchers and life science entrepreneurs to connect with industry leaders in the Australian biotech ecosystem. The official program launch was on the 12th of April 2022 in Sydney. Dr Tayner Rodriguez is participating in the 2022 Bridge Program and will join members of the global pharmaceutical industry to share peer-knowledge, problem-based learning and case-based examples allowing workplace application, helping identify and employ managerial skills for research commercialisation. A three-day Symposium at …

Cancer Therapeutics CRC / Canthera Discovery, of which Discovery Biology has been a founding member since 2007, received the Cooperative Research Australia (CRA) Excellence in Innovation Award for Research Commercialisation at Parliament House in Canberra on the 31st of March, 2022. To accept the award were representatives from the various partners involved, including professor Vicky Avery from Griffith University. This is great recognition for their significant achievements, translating Australian research discoveries into new cancer treatments ready for clinical development. This …